Richard Davis hit a low point early this year after his insurance
company denied him coverage for an effective new therapy for hepatitis
C, a viral illness that damaged his liver and caused him constant pain.
“I have known people who died of (hepatitis C) and it’s not a pleasant death,” Davis, 57, told the Journal, saying his diagnosis with the disease in 2013 left him stunned. “I knew what was coming.”
Davis also knew that he couldn’t pay the huge cost of the two-drug treatment he needed.